New Triple-Threat treatment tested to shrink breast tumors before surgery

NCT ID NCT06178159

Summary

This study is testing whether a new combination of three drugs can safely shrink tumors in people with HER2-positive breast cancer before they have surgery. The treatment aims to eliminate all cancer cells from the breast and lymph nodes by the time of surgery. Researchers will enroll 40 adults with this specific type of breast cancer who haven't had prior cancer treatments.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Fudan University Shanghai Cancer Center

    RECRUITING

    Shanghai, Shanghai Municipality, 200433, China

    Contact

Conditions

Explore the condition pages connected to this study.